Skip to content Skip to footer

Pfizer

HomeAll PostsPfizer
In sum, today's market action reflected deepening caution across asset classes, with macro and policy uncertainties intersecting management commentary for a more sober market tone. Investors are closely watching congressional negotiations on Election Day to end the government shutdown and anticipate further…
Pfizer’s (PFE) move to acquire Metsera (Monday, Sept. 22, 2025) for up to $4.9 billion marks a pivotal expansion in the fast-evolving obesity and diabetes treatment market, intensifying the industry’s GLP-1 rivalry among major pharmaceutical players. Modular Medical (NASDAQ: MODD), with its…